Wittliff JL - Search Results

1

Biosensors for detecting estrogen-like molecules and protein biomarkers.

Wittliff JL, Andres SA, Kruer TL, Kerr DA 2nd, Smolenkova IA, Erb JL. Wittliff JL, et al. Adv Exp Med Biol. 2008;614:315-22. doi: 10.1007/978-0-387-74911-2_35. Adv Exp Med Biol. 2008. PMID: 18290342

2

A three-tiered approach for calibration of a biosensor to detect estrogen mimics.

Andres SA, Kerr DA 2nd, Bumpus SB, Kruer TL, Thieman JW, Smolenkova IA, Wittliff JL. Andres SA, et al. Among authors: wittliff jl. Adv Exp Med Biol. 2008;614:305-13. doi: 10.1007/978-0-387-74911-2_34. Adv Exp Med Biol. 2008. PMID: 18290341

3

Molecular signatures of estrogen receptor-associated genes in breast cancer predict clinical outcome.

Wittliff JL, Kruer TL, Andres SA, Smolenkova I. Wittliff JL, et al. Adv Exp Med Biol. 2008;617:349-57. doi: 10.1007/978-0-387-69080-3_33. Adv Exp Med Biol. 2008. PMID: 18497058

4

Assessment of phytoestrogen and mycoestrogen recognition by recombinant human estrogen receptor-α using ligand titration arrays.

Andres SA, Bumpus SB, Wittliff JL. Andres SA, et al. Among authors: wittliff jl. Phytochem Anal. 2013 Jul-Aug;24(4):357-66. doi: 10.1002/pca.2417. Epub 2013 Feb 8. Phytochem Anal. 2013. PMID: 23401334

5

Characterization of estrogen response element binding proteins as biomarkers of breast cancer behavior.

Kruer TL, Cummins TD, Powell DW, Wittliff JL. Kruer TL, et al. Among authors: wittliff jl. Clin Biochem. 2013 Nov;46(16-17):1739-46. doi: 10.1016/j.clinbiochem.2013.07.005. Epub 2013 Jul 16. Clin Biochem. 2013. PMID: 23868020

6

A five-gene model predicts clinical outcome in ER+/PR+, early-stage breast cancers treated with adjuvant tamoxifen.

Kerr DA 2nd, Wittliff JL. Kerr DA 2nd, et al. Among authors: wittliff jl. Horm Cancer. 2011 Oct;2(5):261-71. doi: 10.1007/s12672-011-0080-8. Horm Cancer. 2011. PMID: 21826535 Free PMC article.

7

Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.

Andres SA, Wittliff JL. Andres SA, et al. Among authors: wittliff jl. Endocrine. 2011 Oct;40(2):212-21. doi: 10.1007/s12020-011-9522-x. Epub 2011 Aug 21. Endocrine. 2011. PMID: 21858728

8

Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance.

Andres SA, Edwards AB, Wittliff JL. Andres SA, et al. Among authors: wittliff jl. J Clin Lab Anal. 2012 Feb;26(2):93-103. doi: 10.1002/jcla.21488. J Clin Lab Anal. 2012. PMID: 22467324 Free PMC article.

9

Protein tyrosine phosphatase 4A2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status.

Andres SA, Wittliff JL, Cheng A. Andres SA, et al. Among authors: wittliff jl. Horm Cancer. 2013 Aug;4(4):208-21. doi: 10.1007/s12672-013-0141-2. Epub 2013 Apr 9. Horm Cancer. 2013. PMID: 23568563 Free PMC article.

10

Gender-associated expression of tumor markers and a small gene set in breast carcinoma.

Andres SA, Smolenkova IA, Wittliff JL. Andres SA, et al. Among authors: wittliff jl. Breast. 2014 Jun;23(3):226-33. doi: 10.1016/j.breast.2014.02.007. Epub 2014 Mar 21. Breast. 2014. PMID: 24656773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

175 results

Search Page

Filters